ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.780
+0.220 (6.18%)
Jun 18, 2026, 2:14 PM HKT

HKG:1541 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,5362,5162,10211,187--
Market Cap Growth
-61.90%19.70%-81.21%---
Enterprise Value
6581,9121,65510,650--
Last Close Price
3.565.835.1629.90--
PS Ratio
8.9514.6526.641319.67--
PB Ratio
1.752.862.9113.57--
P/TBV Ratio
1.742.862.9113.57--
EV/Sales Ratio
3.8311.1420.981256.23--
Debt / Equity Ratio
0.290.290.200.100.02-0.01
Net Debt / Equity Ratio
-1.00-1.00-0.91-0.71-0.800.41
Net Debt / EBITDA Ratio
3.673.672.031.521.763.21
Net Debt / FCF Ratio
3.873.874.451.442.372.81
Asset Turnover
0.150.150.080.010.01-
Inventory Turnover
0.040.04----
Quick Ratio
3.743.743.515.2612.300.27
Current Ratio
3.843.844.045.9312.600.28
Return on Equity (ROE)
-29.87%-29.87%-44.38%-49.68%--
Return on Assets (ROA)
-13.80%-13.80%-21.81%-26.59%-26.29%-
Return on Capital Employed (ROCE)
-27.10%-27.10%-44.30%-48.10%-46.20%13.30%
Earnings Yield
-15.83%-9.67%-15.99%-3.74%--
FCF Yield
-14.77%-9.02%-7.01%-3.65%--
Buyback Yield / Dilution
-9.36%-9.35%-4.24%-9.05%-284.99%-